Dean Li
18Patents
5h-index
19Co-inventors
59Inventor score
Filing activity: Dec 8, 1997 → Jun 3, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6013582A | Method for etching silicon oxynitride and inorganic antireflection coatings | Electricity | 59 | Expired |
| US7456151B2 | Promoting angiogenesis with netrin1 polypeptides | Human Necessities | 46 | Expired |
| US6537918B2 | Method for etching silicon oxynitride and dielectric antireflection coatings | Electricity | 13 | Expired |
| US6291356A | Method for etching silicon oxynitride and dielectric antireflection coatings | Electricity | 12 | Expired |
| US7125837B1 | Elastin-based compositions | Human Necessities | 7 | Expired |
| US8097253B2 | Methods for inhibiting angiogenesis | Human Necessities | 5 | Active |
| US6372958B1 | Transgenic mouse with endogenous endoglin gene disruption | Human Necessities | 3 | Expired |
| US8309519B2 | Compositions and methods for inhibiting vascular permeability | Physics | 2 | Active |
| US9314457B2 | Methods of treating and preventing vascular instability diseases | Human Necessities | 2 | Active |
| US9005356B2 | Tropoelastin for promoting endothelial cell adhesion or migration | Human Necessities | 1 | Active |
| US9937162B2 | Methods of treating and preventing vascular instability diseases | Human Necessities | 1 | Active |
| US7994130B2 | Compositions and methods for treating ocular pathologic angiogenesis and vascular permeability | Physics | 1 | Active |
| US6903244B1 | Mice which are +/− or −/− for the elastin gene as models for vascular disease | Human Necessities | 1 | Expired |
| US7301067B2 | Mice which are +/− or −/− for the elastin gene as models for vascular disease | Human Necessities | 0 | Expired |
| US9381282B2 | Tropoelastin for promoting endothelial cell adhesion or migration | Human Necessities | 0 | Active |
| US10052415B2 | Tropoelastin for promoting endothelial cell adhesion or migration | Human Necessities | 0 | Active |
| US8530043B2 | Composite laminate composition | Emerging Cross-Sectional Technologies | 0 | Active |
| US10849901B2 | Arf6 inhibitors and methods of synthesis and use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.